097950:KRXCJ Cheiljedang Corporation Analysis
Data as of 2026-09-01 - not real-time
₩185,800.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At KRW 185,800.00, CJ Cheiljedang Corporation shows no decisive moving-average alignment, leaving the trend neutral. With RSI at 46.1 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near KRW 179,500.00 and resistance around KRW 207,000.00.
Multiples put this in undervalued territory at a P/E of 6.9. The average analyst target implies 39.2% above today's level. Revenue is growing at 9.5% on a -2.4% profit margin. The 3.17% dividend yield looks stretched against payout coverage.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 37.6%, a beta of 0.54 and a maximum drawdown of 28.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.
Multiples put this in undervalued territory at a P/E of 6.9. The average analyst target implies 39.2% above today's level. Revenue is growing at 9.5% on a -2.4% profit margin. The 3.17% dividend yield looks stretched against payout coverage.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 37.6%, a beta of 0.54 and a maximum drawdown of 28.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.
Top Market Events
Revenue climbs 10% on strong GSP and amino acid sales, but operating profit falls 18.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 208802.00
- MACD momentum is positive
- Maximum drawdown of 28.0%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Dividend yield of 3.17% looks stretched against payout coverage
- Trading below the 200-day average of 208802.00
- Analyst targets imply +39.2% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Dividend yield of 3.17% looks stretched against payout coverage
- Negative profit margin of -2.4%
- Analyst targets imply +39.2% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth9.50%
Profit Margin-2.39%
P/E Ratio6.9
ROE-2.57%
ROA2.31%
Debt/Equity105.58
Op. Cash Flow₩2257.8B
Free Cash Flow₩775.9B
Technical Analysis
TrendNeutral
RSI46.1
Support₩179,500.00
Resistance₩207,000.00
MA 20₩189,725.00
MA 50₩189,604.00
MA 200₩208,802.00
MACDBullish
VolumeDecreasing
Fear & Greed Index93.98
Valuation
Fair Value₩239,267.54
Target Price₩258,687.50
Upside/Downside39.23%
GradeUndervalued
TypeValue
Dividend Yield3.17%
Risk Assessment
Beta0.54
Volatility37.65%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.